# Schedules of Controlled Substances: Placement of Brivaracetam Into Schedule V
> **Rule** · Interim final rule, with request for comments. · Published 2016-05-12 · 81 FR 29487
## Document
- **Document number:** 2016-11245
- **Category:** scheduling
- **Type:** Rule
- **Action:** Interim final rule, with request for comments.
- **Citation:** 81 FR 29487
- **Publication date:** 2016-05-12
## Abstract

The Drug Enforcement Administration is placing the substance brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts) into schedule V of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act, as revised by the Improving Regulatory Transparency for New Medical Therapies Act which was signed into law on November 25, 2015.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2016/05/12/2016-11245/schedules-of-controlled-substances-placement-of-brivaracetam-into-schedule-v)
---
*AI Analytics · CC0 1.0*